<DOC>
	<DOC>NCT00125320</DOC>
	<brief_summary>The purpose of this study is to demonstrate the safety and efficacy of RSD1235 compared to placebo in the conversion of atrial arrhythmia to sinus rhythm in subjects following valvular and/or coronary artery bypass graft surgery.</brief_summary>
	<brief_title>Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery</brief_title>
	<detailed_description>This multi-national, multi-center study is a double blind, randomized, placebo-controlled trial with 2 parallel treatment arms (1 active, 1 placebo) to assess the conversion efficacy and safety of 2 intravenous doses of RSD1235 in subjects with atrial fibrillation or atrial flutter following valvular and/or coronary artery bypass graft (CABG) surgery.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<criteria>Documented atrial arrhythmia after valvular and/or coronary artery bypass graft surgery Unstable Class IV heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Treatment</keyword>
</DOC>